Annual CFO
-$14.09 M
+$12.67 M+47.35%
31 December 2023
Summary:
BIOLASE annual cash flow from operations is currently -$14.09 million, with the most recent change of +$12.67 million (+47.35%) on 31 December 2023. During the last 3 years, it has fallen by -$1.30 million (-10.13%). BIOL annual CFO is now -316.32% below its all-time high of $6.51 million, reached on 31 December 2003.BIOL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$4.47 M
-$3.74 M-509.26%
30 September 2024
Summary:
BIOLASE quarterly cash flow from operations is currently -$4.47 million, with the most recent change of -$3.74 million (-509.26%) on 30 September 2024. Over the past year, it has dropped by -$1.88 million (-72.80%). BIOL quarterly CFO is now -178.91% below its all-time high of $5.67 million, reached on 31 December 2003.BIOL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$13.43 M
-$1.88 M-16.32%
30 September 2024
Summary:
BIOLASE TTM cash flow from operations is currently -$13.43 million, with the most recent change of -$1.88 million (-16.32%) on 30 September 2024. Over the past year, it has increased by +$3.96 million (+22.79%). BIOL TTM CFO is now -306.13% below its all-time high of $6.51 million, reached on 31 December 2003.BIOL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIOL Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.4% | -72.8% | +22.8% |
| 3 y3 years | -10.1% | -24.3% | +10.2% |
| 5 y5 years | +0.4% | -209.1% | -15.4% |
BIOL Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -10.1% | +47.4% | -509.3% | +44.3% | -16.3% | +49.8% |
| 5 y | 5 years | -10.6% | +47.4% | -509.3% | +44.3% | -16.3% | +49.8% |
| alltime | all time | -316.3% | +47.4% | -178.9% | +55.1% | -306.1% | +49.8% |
BIOLASE Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.47 M(+509.3%) | -$13.43 M(+16.3%) |
| June 2024 | - | -$734.00 K(-87.6%) | -$11.54 M(-19.7%) |
| Mar 2024 | - | -$5.94 M(+160.1%) | -$14.37 M(+2.0%) |
| Dec 2023 | -$14.09 M(-47.3%) | -$2.28 M(-11.8%) | -$14.09 M(-19.0%) |
| Sept 2023 | - | -$2.59 M(-27.3%) | -$17.39 M(-18.5%) |
| June 2023 | - | -$3.56 M(-37.0%) | -$21.35 M(-12.5%) |
| Mar 2023 | - | -$5.66 M(+1.4%) | -$24.40 M(-8.8%) |
| Dec 2022 | -$26.76 M(+60.1%) | -$5.58 M(-14.7%) | -$26.76 M(+10.2%) |
| Sept 2022 | - | -$6.55 M(-1.0%) | -$24.28 M(+13.8%) |
| June 2022 | - | -$6.61 M(-17.6%) | -$21.34 M(+17.0%) |
| Mar 2022 | - | -$8.02 M(+158.4%) | -$18.23 M(+9.1%) |
| Dec 2021 | -$16.71 M(+30.6%) | -$3.10 M(-13.7%) | -$16.71 M(+11.7%) |
| Sept 2021 | - | -$3.60 M(+2.5%) | -$14.95 M(+11.1%) |
| June 2021 | - | -$3.51 M(-46.0%) | -$13.46 M(-11.2%) |
| Mar 2021 | - | -$6.50 M(+382.1%) | -$15.16 M(+18.5%) |
| Dec 2020 | -$12.79 M(+0.4%) | -$1.35 M(-36.1%) | -$12.79 M(-20.6%) |
| Sept 2020 | - | -$2.11 M(-59.5%) | -$16.12 M(+4.3%) |
| June 2020 | - | -$5.21 M(+25.9%) | -$15.46 M(+30.5%) |
| Mar 2020 | - | -$4.13 M(-11.5%) | -$11.85 M(-7.1%) |
| Dec 2019 | -$12.75 M(-9.9%) | -$4.67 M(+222.9%) | -$12.75 M(+9.6%) |
| Sept 2019 | - | -$1.45 M(-9.2%) | -$11.63 M(-6.4%) |
| June 2019 | - | -$1.59 M(-68.4%) | -$12.43 M(-13.8%) |
| Mar 2019 | - | -$5.03 M(+41.5%) | -$14.42 M(+1.9%) |
| Dec 2018 | -$14.15 M(-23.2%) | -$3.56 M(+58.4%) | -$14.15 M(-4.7%) |
| Sept 2018 | - | -$2.25 M(-37.3%) | -$14.85 M(-6.3%) |
| June 2018 | - | -$3.58 M(-24.8%) | -$15.85 M(-12.2%) |
| Mar 2018 | - | -$4.76 M(+11.9%) | -$18.05 M(-2.0%) |
| Dec 2017 | -$18.41 M(+73.8%) | -$4.26 M(+31.0%) | -$18.41 M(+6.4%) |
| Sept 2017 | - | -$3.25 M(-43.8%) | -$17.30 M(+13.6%) |
| June 2017 | - | -$5.79 M(+12.9%) | -$15.23 M(+39.1%) |
| Mar 2017 | - | -$5.12 M(+63.0%) | -$10.95 M(+3.3%) |
| Dec 2016 | -$10.60 M(-40.4%) | -$3.14 M(+166.8%) | -$10.60 M(+3.2%) |
| Sept 2016 | - | -$1.18 M(-21.6%) | -$10.27 M(-21.0%) |
| June 2016 | - | -$1.50 M(-68.5%) | -$13.01 M(-14.1%) |
| Mar 2016 | - | -$4.77 M(+69.3%) | -$15.14 M(-14.8%) |
| Dec 2015 | -$17.77 M(+9.7%) | -$2.82 M(-28.0%) | -$17.77 M(-14.9%) |
| Sept 2015 | - | -$3.92 M(+7.6%) | -$20.88 M(-14.2%) |
| June 2015 | - | -$3.64 M(-50.9%) | -$24.34 M(+17.0%) |
| Mar 2015 | - | -$7.40 M(+24.9%) | -$20.81 M(+28.4%) |
| Dec 2014 | -$16.20 M(+74.3%) | -$5.93 M(-19.6%) | -$16.20 M(+29.9%) |
| Sept 2014 | - | -$7.37 M(+6921.0%) | -$12.48 M(+75.6%) |
| June 2014 | - | -$105.00 K(-96.2%) | -$7.10 M(-23.4%) |
| Mar 2014 | - | -$2.80 M(+27.0%) | -$9.27 M(-0.3%) |
| Dec 2013 | -$9.30 M(+458.7%) | -$2.20 M(+10.2%) | -$9.30 M(+77.7%) |
| Sept 2013 | - | -$2.00 M(-12.1%) | -$5.23 M(+50.1%) |
| June 2013 | - | -$2.27 M(-19.5%) | -$3.48 M(-10.5%) |
| Mar 2013 | - | -$2.82 M(-251.5%) | -$3.89 M(+134.0%) |
| Dec 2012 | -$1.66 M(-87.5%) | $1.86 M(-836.4%) | -$1.66 M(-70.0%) |
| Sept 2012 | - | -$253.00 K(-90.6%) | -$5.54 M(-41.6%) |
| June 2012 | - | -$2.68 M(+352.1%) | -$9.49 M(+7.3%) |
| Mar 2012 | - | -$593.00 K(-70.6%) | -$8.85 M(-33.6%) |
| Dec 2011 | -$13.32 M(+249.4%) | -$2.02 M(-51.9%) | -$13.32 M(+15.4%) |
| Sept 2011 | - | -$4.20 M(+105.9%) | -$11.55 M(+39.9%) |
| June 2011 | - | -$2.04 M(-59.7%) | -$8.25 M(-12.8%) |
| Mar 2011 | - | -$5.06 M(+1966.9%) | -$9.46 M(+148.2%) |
| Dec 2010 | -$3.81 M(+48.3%) | -$245.00 K(-72.9%) | -$3.81 M(-12.5%) |
| Sept 2010 | - | -$904.00 K(-72.2%) | -$4.36 M(+35.0%) |
| June 2010 | - | -$3.25 M(-655.2%) | -$3.23 M(-285.0%) |
| Mar 2010 | - | $585.00 K(-174.2%) | $1.74 M(-167.8%) |
| Dec 2009 | -$2.57 M | -$788.00 K(-448.7%) | -$2.57 M(-61.4%) |
| Sept 2009 | - | $226.00 K(-86.9%) | -$6.66 M(-33.6%) |
| June 2009 | - | $1.72 M(-146.1%) | -$10.02 M(+10.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2009 | - | -$3.73 M(-23.5%) | -$9.05 M(+100.2%) |
| Dec 2008 | -$4.52 M(+38.3%) | -$4.87 M(+55.1%) | -$4.52 M(-805.1%) |
| Sept 2008 | - | -$3.14 M(-216.5%) | $641.00 K(-81.3%) |
| June 2008 | - | $2.69 M(+237.3%) | $3.44 M(-733.8%) |
| Mar 2008 | - | $799.00 K(+177.4%) | -$542.00 K(-83.4%) |
| Dec 2007 | -$3.27 M(-869.2%) | $288.00 K(-183.0%) | -$3.27 M(-47.3%) |
| Sept 2007 | - | -$347.00 K(-72.9%) | -$6.20 M(+49.6%) |
| June 2007 | - | -$1.28 M(-33.5%) | -$4.14 M(+2489.4%) |
| Mar 2007 | - | -$1.93 M(-27.0%) | -$160.00 K(-137.6%) |
| Dec 2006 | $425.00 K(-102.5%) | -$2.64 M(-254.6%) | $425.00 K(-89.7%) |
| Sept 2006 | - | $1.71 M(-36.8%) | $4.12 M(-229.5%) |
| June 2006 | - | $2.70 M(-301.1%) | -$3.19 M(-62.2%) |
| Mar 2006 | - | -$1.34 M(-227.1%) | -$8.43 M(-50.6%) |
| Dec 2005 | -$17.05 M(+985.4%) | $1.06 M(-118.9%) | -$17.05 M(-9.4%) |
| Sept 2005 | - | -$5.60 M(+120.2%) | -$18.82 M(+38.2%) |
| June 2005 | - | -$2.54 M(-74.5%) | -$13.62 M(+23.2%) |
| Mar 2005 | - | -$9.96 M(+1297.6%) | -$11.05 M(+603.7%) |
| Dec 2004 | -$1.57 M(-124.1%) | -$713.00 K(+80.1%) | -$1.57 M(-132.7%) |
| Sept 2004 | - | -$396.00 K(-2184.2%) | $4.81 M(+1.6%) |
| June 2004 | - | $19.00 K(-104.0%) | $4.73 M(-17.5%) |
| Mar 2004 | - | -$481.00 K(-108.5%) | $5.74 M(-11.9%) |
| Dec 2003 | $6.51 M(+1265.6%) | $5.67 M(-1295.6%) | $6.51 M(+297.9%) |
| Sept 2003 | - | -$474.00 K(-146.2%) | $1.64 M(-34.0%) |
| June 2003 | - | $1.02 M(+246.3%) | $2.48 M(+52.2%) |
| Mar 2003 | - | $296.00 K(-62.5%) | $1.63 M(+241.5%) |
| Dec 2002 | $477.00 K(-144.3%) | $790.00 K(+114.1%) | $477.00 K(-440.7%) |
| Sept 2002 | - | $369.00 K(+112.1%) | -$140.00 K(-91.0%) |
| June 2002 | - | $174.00 K(-120.3%) | -$1.56 M(+33.3%) |
| Mar 2002 | - | -$856.00 K(-594.8%) | -$1.17 M(+8.5%) |
| Dec 2001 | -$1.08 M(-71.5%) | $173.00 K(-116.5%) | -$1.08 M(+71.1%) |
| Sept 2001 | - | -$1.05 M(-286.0%) | -$628.70 K(-33.0%) |
| June 2001 | - | $563.10 K(-173.6%) | -$937.70 K(-70.6%) |
| Mar 2001 | - | -$764.80 K(-223.3%) | -$3.19 M(-15.5%) |
| Dec 2000 | -$3.78 M(+99.1%) | $620.30 K(-145.7%) | -$3.78 M(-17.8%) |
| Sept 2000 | - | -$1.36 M(-19.8%) | -$4.60 M(+26.3%) |
| June 2000 | - | -$1.69 M(+25.1%) | -$3.64 M(+12.0%) |
| Mar 2000 | - | -$1.35 M(+585.0%) | -$3.25 M(+71.2%) |
| Dec 1999 | -$1.90 M(-60.5%) | -$197.30 K(-50.7%) | -$1.90 M(-17.5%) |
| Sept 1999 | - | -$400.00 K(-69.2%) | -$2.30 M(-41.0%) |
| June 1999 | - | -$1.30 M(<-9900.0%) | -$3.90 M(+21.9%) |
| Mar 1999 | - | $0.00(-100.0%) | -$3.20 M(-33.3%) |
| Dec 1998 | -$4.80 M(+20.0%) | -$600.00 K(-70.0%) | -$4.80 M(-17.2%) |
| Sept 1998 | - | -$2.00 M(+233.3%) | -$5.80 M(+34.9%) |
| June 1998 | - | -$600.00 K(-62.5%) | -$4.30 M(-10.4%) |
| Mar 1998 | - | -$1.60 M(0.0%) | -$4.80 M(+20.0%) |
| Dec 1997 | -$4.00 M(+81.8%) | -$1.60 M(+220.0%) | -$4.00 M(+29.0%) |
| Sept 1997 | - | -$500.00 K(-54.5%) | -$3.10 M(0.0%) |
| June 1997 | - | -$1.10 M(+37.5%) | -$3.10 M(+24.0%) |
| Mar 1997 | - | -$800.00 K(+14.3%) | -$2.50 M(+13.6%) |
| Dec 1996 | -$2.20 M(+29.4%) | -$700.00 K(+40.0%) | -$2.20 M(+22.2%) |
| Sept 1996 | - | -$500.00 K(0.0%) | -$1.80 M(+5.9%) |
| June 1996 | - | -$500.00 K(0.0%) | -$1.70 M(+13.3%) |
| Mar 1996 | - | -$500.00 K(+66.7%) | -$1.50 M(-11.8%) |
| Dec 1995 | -$1.70 M(-34.6%) | -$300.00 K(-25.0%) | -$1.70 M(+21.4%) |
| Sept 1995 | - | -$400.00 K(+33.3%) | -$1.40 M(+40.0%) |
| June 1995 | - | -$300.00 K(-57.1%) | -$1.00 M(+42.9%) |
| Mar 1995 | - | -$700.00 K(-30.0%) | -$700.00 K(-87.9%) |
| Dec 1994 | -$2.60 M(-55.2%) | - | - |
| Dec 1993 | -$5.80 M(+7.4%) | -$1.00 M(-44.4%) | -$5.80 M(+20.8%) |
| Sept 1993 | - | -$1.80 M(+12.5%) | -$4.80 M(+60.0%) |
| June 1993 | - | -$1.60 M(+14.3%) | -$3.00 M(+114.3%) |
| Mar 1993 | - | -$1.40 M | -$1.40 M |
| Dec 1992 | -$5.40 M | - | - |
FAQ
- What is BIOLASE annual cash flow from operations?
- What is the all time high annual CFO for BIOLASE?
- What is BIOLASE annual CFO year-on-year change?
- What is BIOLASE quarterly cash flow from operations?
- What is the all time high quarterly CFO for BIOLASE?
- What is BIOLASE quarterly CFO year-on-year change?
- What is BIOLASE TTM cash flow from operations?
- What is the all time high TTM CFO for BIOLASE?
- What is BIOLASE TTM CFO year-on-year change?
What is BIOLASE annual cash flow from operations?
The current annual CFO of BIOL is -$14.09 M
What is the all time high annual CFO for BIOLASE?
BIOLASE all-time high annual cash flow from operations is $6.51 M
What is BIOLASE annual CFO year-on-year change?
Over the past year, BIOL annual cash flow from operations has changed by +$12.67 M (+47.35%)
What is BIOLASE quarterly cash flow from operations?
The current quarterly CFO of BIOL is -$4.47 M
What is the all time high quarterly CFO for BIOLASE?
BIOLASE all-time high quarterly cash flow from operations is $5.67 M
What is BIOLASE quarterly CFO year-on-year change?
Over the past year, BIOL quarterly cash flow from operations has changed by -$1.88 M (-72.80%)
What is BIOLASE TTM cash flow from operations?
The current TTM CFO of BIOL is -$13.43 M
What is the all time high TTM CFO for BIOLASE?
BIOLASE all-time high TTM cash flow from operations is $6.51 M
What is BIOLASE TTM CFO year-on-year change?
Over the past year, BIOL TTM cash flow from operations has changed by +$3.96 M (+22.79%)